Chris Waine

Chris Waine

Principal Toxicologist and Director

Qualifications

MChem in Chemistry with Forensic Science

UK Registered Toxicologist (UKRT)

European Registered Toxicologist (ERT)

Chartered Chemist

Chris Waine,
Principal Toxicologist and Director

Chris joined bibra at the beginning of 2013 after gaining an MChem in Chemistry with Forensic Science from the University of Manchester, and has been a European Registered Toxicologist since 2018.

He leads on several of bibra’s projects relating to the REACH regulation, helping clients in several sectors meet their registration obligations and respond to evaluation decisions. Chris is also heavily involved in projects in the medicines and medical devices areas, particularly the assessment of impurities and of extractables and leachables. He is also skilled at running (Q)SAR predictions of toxicology and incorporating these results into bibra’s reports. He works closely with Leadscope on several of their working groups, and is an expert panel member of the BSI and ISO Technical Committees relating to ISO 10993 on the biological evaluation of medical devices.

Outside of the office, Chris enjoys a wide range of music, and can often be found at the piano or with one of his guitars. He is an avid sports fan and enjoys regular trips to visit family and friends around Europe.

Chris's case studies and blog posts

REACH registration of nearly 100 related metal compounds

Case study

Manufacturers of chemicals in, or importers into, the European Union are required under the REACH regulation to submit a dossier of information on their substances to ECHA.

In silico prediction of genotoxicity and carcinogenicity

Case study

As part of their overall regulatory requirements, the client was asked to provide an assessment of the known or predicted genotoxicity and carcinogenicity of a number of ingredients in their products. Bibra were provided with a list of several substances and asked to carry out this work following the genetic toxicology in silico (GIST) protocol.

NAMs for NGRAs

Blog articles

Traditionally, toxicological risk assessment has involved identifying a point of departure (PoD) such as a NOAEL or LOAEL in a study of small creatures, adjusting it to be relevant to humans (to derive, for example, a TI or DNEL), and then calculating the margin of safety to a measured or estimated external exposure. As part of this process, toxicologists have to account for the uncertainties that arise in moving from the species, route and duration of the laboratory animal study to the real human world.

Want to read more case studies and blog posts that Chris has been involved in? Click below to read more.

Contact us